XBiotech Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.5% | -0.5% | +0.7% | +0.9% | +0.0% | +0.7% | -0.7% | -2.7% | -11.5% | -12.2% | -9.0% | – | |
| – | -28.0% | -44.6% | -0.5% | -3.7% | +72.1% | +430.1% | -96.8% | -77.6% | +575.0% | +6.2% | +0.0% | – | |
| – | -61.3% | -69.5% | -35.3% | -453.8% | – | – | -350.8% | – | +4,660.4% | -211.6% | – | – | |
| – | +248.5% | +121.7% | +145.9% | -46.1% | -75.1% | +11.9% | -45.7% | +115.7% | -69.1% | -100.0% | – | – | |
| – | -100.2% | +121.7% | +145.9% | -46.1% | -75.1% | +11.9% | -45.7% | +115.7% | -69.1% | – | -144.4% | – | |
| – | – | – | – | – | – | -4,200.0% | -100.0% | – | – | – | – | – | |
| – | -184,500.0% | – | -99.5% | +33.3% | +342.2% | -3,721.9% | -100.0% | – | – | – | – | – | |
| – | -103.7% | – | -1,331.2% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.